Twitter LinkedIn YouTube

Late-Breaking Abstract Titles Now Available on the SITC 2016 Meeting App

The Society for Immunotherapy of Cancer (SITC) is excited to announce that the late-breaking abstract titles are now available. These abstracts directly contribute to the scientific exchange and education that SITC 2016 has to offer. Browse abstract titles by downloading the SITC 2016 meeting app!

The abstract embargo will lift on Tuesday, November 8, at 8:00 a.m. EST, and all accepted regular abstracts will be accessible via a special supplement published in SITC’s official journal, the Journal for ImmunoTherapy of Cancer (JITC). All accepted late-breaking abstracts will be published on December 8 in JITC.

Novel Data You Must See

SITC's 31st Annual Meeting features two late-breaking abstract sessions filled with cutting-edge clinical and pre-clinical data from leaders in the cancer immunotherapy field. These sessions will feature the following oral abstracts:

  • Efficacy and Safety of Nivolumab Plus Ipilimumab in Metastatic Urothelial Carcinoma: First Results From the Phase I/II From the Phase I/II CheckMate 032 Study
    Presenting Author: Padmanee Sharma, MD, PhD – University of Texas MD Anderson Cancer Center
  • Computational Identification, Functional Characterization and Antibody Blockade of a New Immune Checkpoint in the TIGIT Family of Interacting Molecules
    Presenting Author: John Hunter, PhD – Compugen USA, Inc.
  • Combinatorial CD8+ and PD-L1 + Cell Densities Correlate with Response and Improved Survival in NSCLC Patients Treated with Durvalumab
    Presenting Author: Sonja Althammer, PhD – Definiens
  • Preliminary Efficacy from a Phase 1/2 Study of the Natural Killer Cell-Targeted Antibody, Lirilumab in Combination with Nivolumab in Squamous Cell Carcinoma of the Head and Neck
    Presenting Author: Rom Leidner, MD – Earl A. Chiles Research Institute, Providence Cancer Center

Don't Miss the SITC Oral Poster Sessions

Beyond regular poster viewing, SITC welcomes the Oral Poster Sessions. These sessions provide select poster presenters with the opportunity to orally share their work with the SITC audience. The Oral Poster Session presentations will take place Friday, November 11 from 12:30 – 1:20 p.m. and Saturday, November 12 from noon – 12:50 p.m. in the Prince George's Exhibition Hall AB. A detailed daily schedule is available on the SITC 2016 Meeting App.

Download the SITC 2016 Meeting App

When you download the SITC 2016 meeting app, you'll have the entire 31st Annual Meeting & Associated Programs at your fingertips! 

Create your personal schedule. View session information, plan your time and create a personalized schedule to maximize every moment spent at SITC 2016!

Search for your favorite faculty, abstracts and topics. View the full listing of SITC 2016’s extensive and world-class faculty! Search for your colleagues who will be presenting abstracts, giving presentations or to network with the field’s top researchers and oncologists.

Connect with your colleagues. Utilizing the app’s various social media and messaging functions is your way to make lasting connections before, during and after the meeting.

Visit the App Store (iOS) or Google Play (Android) to download the SITC 2016 Meeting App.

Advance Registration Ends November 1—Register Now!

While onsite registration will be available, it is recommended that you take advantage of the advance registration option to ensure your place at the world's leading cancer immunotherapy conference and register now! As with all of our live programs, SITC members enjoy reduced registration rates. If you are not yet a SITC member, or have yet to renew your dues, simply apply or renew online to qualify for reduced SITC 2016 registration rates! 

Visit the SITC 2016 site to discover all that the leading cancer immunotherapy conference has to offer! 

sitc logo

Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email: education@sitcancer.org

© 2016 Society for Immunotherapy of Cancer


If you do not wish to be included in our mailing list, please forward this message to education@sitcancer.org with the word "Remove" in the subject line.